|
571 |
The ACE Gene and Human Performance
Enthalten in Sports medicine Bd. 41, 7.10.2012, Nr. 6, date:6.2011: 433-448
|
|
|
|
572 |
The Analysis and Utilization of Cycling Training Data
Enthalten in Sports medicine Bd. 39, 23.10.2012, Nr. 10, date:10.2009: 833-844
|
|
|
|
573 |
The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions
Enthalten in PharmacoEconomics Bd. 28, 17.9.2012, Nr. 12, date:12.2010: 1079-1096
|
|
|
|
574 |
The Appropriate Elicitation of Expert Opinion in Economic Models
Enthalten in PharmacoEconomics Bd. 29, 11.12.2012, Nr. 6, date:6.2011: 455-459
|
|
|
|
575 |
The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinson’s Disease
Enthalten in CNS drugs Bd. 25, 29.8.2012, Nr. 1, date:1.2011: 53-66
|
|
|
|
576 |
The Authors’ Reply
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 6, date:6.2012: 532-533
|
|
|
|
577 |
The Authors’ Reply
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 10, date:10.2012: 977-978
|
|
|
|
578 |
The Authors’ Reply
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 10, date:10.2012: 980
|
|
|
|
579 |
The Authors’ Reply
Enthalten in Clinical pharmacokinetics Bd. 48, 13.9.2012, Nr. 10, date:10.2009: 686-687
|
|
|
|
580 |
The Case for Less, Not More, US FDA Regulation
Enthalten in PharmacoEconomics Bd. 29, 23.9.2012, Nr. 8, date:8.2011: 637-640
|
|
Administration
